loadpatents
name:-0.0088131427764893
name:-0.0089750289916992
name:-0.001655101776123
Dornfeld; Leslie Patent Filings

Dornfeld; Leslie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dornfeld; Leslie.The latest application filed is for "compositions and methods using pomegranate extracts".

Company Profile
0.8.4
  • Dornfeld; Leslie - Los Angeles CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods using pomegranate extracts
Grant 9,295,703 - Aviram , et al. March 29, 2
2016-03-29
Compositions And Methods Using Pomegranate Extracts
App 20150209394 - Aviram; Michael ;   et al.
2015-07-30
Compositions and methods using pomegranate extracts
Grant 8,936,818 - Aviram , et al. January 20, 2
2015-01-20
Compositions And Methods Using Pomegranate Extracts
App 20120276228 - Aviram; Michael ;   et al.
2012-11-01
Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
Grant 8,221,806 - Aviram , et al. July 17, 2
2012-07-17
Process for producing a therapeutically effective amount of an extract from pomegranate and compositions relating to same
Grant 7,780,998 - Aviram , et al. August 24, 2
2010-08-24
Methods for treating hypertension in a subject using pomegranate extracts
Grant 7,645,469 - Aviram , et al. January 12, 2
2010-01-12
Process For Producing A Therapeutically Effective Amount Of An Extract From Pomegranate And Compositions Relating To Same
App 20070178180 - AVIRAM; Michael ;   et al.
2007-08-02
Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
App 20060057235 - Aviram; Michael ;   et al.
2006-03-16
Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
Grant 6,977,089 - Aviram , et al. December 20, 2
2005-12-20
Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
Grant 6,641,850 - Aviram , et al. November 4, 2
2003-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed